SPIMA Therapeutics
PrivateLast Round
Seed
Sep 30, 2024
Total Funding Raised
$1.12M
Company Overview
SPIMA Therapeutics is a biotechnology company that develops innovative peptide-based immunotherapies to address undruggable targets and protein-protein interactions for the treatment of severe immunological disorders and aggressive cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SPIMA Therapeutics Comparables
Compare SPIMA Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Duhn Therapeutics | 72% | |
| BiPER Therapeutics | 71% | |
| Massalia Therapeutics | 71% |
SPIMA Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 30, 2024 |
SPIMA Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SATT AxLR | Seed |
SPIMA Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SPIMA Therapeutics's valuation, stock price, and market status.
Is SPIMA Therapeutics a public or private company?
SPIMA Therapeutics is a private company.
What is the current stock price of SPIMA Therapeutics?
SPIMA Therapeutics is a private company, so its shares have no public market price. Caplight tracks SPIMA Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SPIMA Therapeutics worth (valuation)?
Valuation information for SPIMA Therapeutics is not publicly available.
Can I buy SPIMA Therapeutics stock?
SPIMA Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SPIMA Therapeutics's last funding round?
SPIMA Therapeutics's most recent funding round was Seed on September 30, 2024.
Who are the main investors in SPIMA Therapeutics?
Key investors in SPIMA Therapeutics include SATT AxLR.
Will SPIMA Therapeutics IPO soon?
No public IPO plans have been announced for SPIMA Therapeutics.
How can I track SPIMA Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in SPIMA Therapeutics's shares on secondary markets.